Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722173 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket



Company Study of Huadong Medicine
Research In China, May 2008, Pages: 33


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22, 1999, the company went public on the Shenzhen Stock Exchange and raised around CNY288 million through issuing 5,000 shares. Its main business covers the production and sale of chemical medicine and traditional Chinese medicine.

Huadong Medicine's main business revenue covers two parts-pharmacy industry and pharmacy business. Since the gross profit margin of pharmacy industry is much higher than the pharmacy business, Huadong Medicine has been making vigorous efforts to open up the market of the pharmacy industry, which has made the proportion of its pharmacy industry to the total main business revenue increase year by year. This is one of the key reasons that the company's performance rose gradually in the recently years.

According to the company's announcement on April 3, 2008, Huadong Medicine plans to acquire 78.87% stake in Xi'an Bohua Pharmaceutical Co., Ltd. and 65% stake in the latter's subsidiary named Shaanxi Jiuzhou Medicine Co., Ltd. for CNY98 million. The acquisition, if done, will not only help the company reinforce its strength in special pharmaceutical raw materials, but also enter the narcotic market with high barriers to enter.


This title is also available in the following language

Company Study of Huadong Medicine (Chinese Version)



Customers who bought this item also bought

Company Study of Huadong Medicine

Huadong Medicine Company Limited

Nanjing Huadong Electron Information Tech.

Alternative Medicine - Global Outlook

Market Research of Diabetes and its Treatment Medicine-Insulin in China, 2008

Regenerative Medicine - Global Strategic Business Report

Personalized Medicine - Scientific and Commercial Aspects

Regenerative Medicine - Global Market Trends

Dealmaking and Business Strategies in the Age of Personalized Medicine

Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007

Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007

Report of Traditional Chinese Medicine Industry under, 2009



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds